共 50 条
PulseRider Stent-Assisted Coiling of Wide-Neck Bifurcation Aneurysms: Periprocedural Results in an International Series
被引:43
|作者:
Gory, B.
[1
]
Spiotta, A. M.
[2
]
Mangiafico, S.
[3
]
Consoli, A.
[3
]
Biondi, A.
[4
]
Pomero, E.
[4
]
Killer-Oberpfalzer, M.
[5
]
Weber, W.
[6
]
Riva, R.
[1
]
Labeyrie, P. E.
[1
]
Turjman, F.
[1
]
机构:
[1] Hosp Civils Lyon, Hop Neurol Pierre Wertheimer, Dept Intervent Neuroradiol, DHU IRIS, F-69677 Bron, France
[2] Med Univ S Carolina, Dept Neurosci, Div Neurosurg, Charleston, SC 29425 USA
[3] Careggi Univ Hosp, Dept Neuroradiol, Florence, Italy
[4] Univ Franche Comte, Jean Minjoz Hosp, Dept Neuroradiol & Endovasc Therapy, F-25030 Besancon, France
[5] Paracelsus Med Univ, Christian Doppler Clin, Dept Neurol, Inst Neurosci, Salzburg, Austria
[6] Knappschaftskrankenhaus, Dept Neuroradiol, Recklinghausen, Germany
关键词:
RUPTURED CEREBRAL ANEURYSMS;
ENDOVASCULAR TREATMENT;
INTRACRANIAL ANEURYSMS;
ARTERY ANEURYSMS;
SHORT-TERM;
DETACHABLE COILS;
TRIAL ISAT;
MULTICENTER;
COHORT;
D O I:
10.3174/ajnr.A4506
中图分类号:
R74 [神经病学与精神病学];
学科分类号:
摘要:
The PulseRider is a novel endovascular device specifically designed to treat bifurcation intracranial aneurysms with wide necks. In an international series, we report the results of PulseRider stent-assisted coiling of 15 patients (9 women and 6 men; mean age, 62.6 years) with 15 unruptured wide-neck (median dome size, 8 mm; median neck size, 5 mm) bifurcation aneurysms. Failure of PulseRider treatment occurred in 1 case, and 1 intraprocedural thromboembolic complication was observed. There was no mortality or neurologic permanent morbidity at discharge and at 1 month. Immediate angiographic outcome showed 12 complete occlusions and 2 neck remnants. Follow-up at 6 months was available for 3 aneurysms and demonstrated 2 complete aneurysm occlusions and 1 growing neck remnant. In this small series of selected patients, PulseRider stent-assisted coiling of wide-neck bifurcation aneurysms was feasible with low procedural complication rates. Angiographic follow-up will be required to evaluate the efficacy of the PulseRider device.
引用
收藏
页码:130 / 135
页数:6
相关论文